ABVE - Above Food Ingredie... Stock Analysis | Stock Taper
Logo
Above Food Ingredients Inc. Common Stock

ABVE

Above Food Ingredients Inc. Common Stock NASDAQ
$1.25 -7.41% (-0.10)

Market Cap $63.99 M
52w High $6.56
52w Low $0.25
P/E -0.71
Volume 1.17M
Outstanding Shares 51.19M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2024 $45.03M $14M $-18.2M -40.43% $-1.75 $-9.52M
Q1-2024 $0 $774.12K $-32.62K 0% $-0 $-774.12K
Q4-2023 $94.72M $12.75M $-22.65M -23.91% $-2.69 $-16M
Q3-2023 $0 $668.98K $123.99K 0% $0.01 $-668.98K
Q2-2023 $0 $1.59M $-742.43K 0% $-0.09 $-1.59M

What's going well?

The company finally started generating significant revenue, showing it can sell its product or service. This could be the start of a new growth phase if costs can be controlled.

What's concerning?

Losses exploded as costs were much higher than sales, and gross margins are negative. If this trend continues, the company will burn cash quickly and may need to raise more money.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2024 $664.43K $112.35M $227.56M $-115.21M
Q1-2024 $5.81K $34.75M $5.96M $28.79M
Q4-2023 $947 $30.92M $4.08M $-46.26M
Q3-2023 $260.4K $160.56M $184.87M $-24.31M
Q2-2023 $12.32K $41.21M $4.39M $36.83M

What's financially strong about this company?

The company has invested heavily in property and equipment, and is seeing more business activity with higher receivables and inventory. Some customers are paying upfront, as shown by deferred revenue.

What are the financial risks or weaknesses?

Debt has exploded and now far exceeds assets, equity is deeply negative, and cash is extremely low. The company is at high risk of running out of money and may need to raise more funds just to survive.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2024 $-18.2K $166.99 $897.95 $-1.21K $0 $-60.19
Q1-2024 $-32.62K $-799.5K $7.74M $-6.93M $4.52K $-799.5K
Q4-2023 $229.05K $-285.45K $-171K $456.68K $227 $-647.51K
Q3-2023 $123.99K $-301.51K $1.44M $-1.15M $-11.62K $-301.51K
Q2-2023 $-742.43K $-742.23K $-112.37K $814.73K $-39.87K $-742.23K

What's strong about this company's cash flow?

Operating cash flow flipped from a huge loss to a solid positive number. The company is no longer relying on outside money and is close to covering its own costs.

What are the cash flow concerns?

Free cash flow is still negative, meaning the business is not fully self-sustaining yet. Inventory and receivables are rising, which could hurt future cash flow.

5-Year Trend Analysis

A comprehensive look at Above Food Ingredients Inc. Common Stock's financial evolution and strategic trajectory over the past five years.

+ Strengths

The company’s key strengths are its rapid revenue ramp-up, differentiated positioning in regenerative and plant-based foods, and vertically integrated “seed-to-fork” model. It has assembled a portfolio of technologies and acquisitions—covering seed labs, processing innovations, and specialty ingredients—that give it a broad platform for future growth. Recent improvements in operating and free cash flow, along with a strategic tilt toward higher-margin specialty ingredients, suggest management is aware of the need to move from growth to economic discipline.

! Risks

The most significant risks are financial. Gross, operating, and net margins are deeply negative; losses are large and growing; equity is now negative; and debt and short-term obligations are high relative to liquidity. This creates solvency and refinancing risk at the same time the company is trying to execute complex integrations and ambitious innovation projects. Competitive and execution risks are also material, given the presence of powerful incumbents, the volatility in consumer trends, and the operational demands of running a vertically integrated, global supply chain.

Outlook

The outlook is finely balanced between strategic promise and financial strain. If Above Food can improve unit economics, stabilize margins, and manage its debt load while continuing to leverage its technology, regenerative platform, and specialty ingredients focus, it could evolve into a more resilient, higher-quality business. Conversely, if revenue growth remains sluggish and losses do not narrow, the current balance-sheet pressures could constrain its ability to invest and execute on its innovation roadmap. Overall, the company appears to be at an inflection point where operational discipline and capital management will be as important as vision and innovation.